VIVES Louvain Technology Fund
Overview
VIVES Louvain Technology Fund is a venture capital firm initiated by Université catholique de Louvain (UCLouvain) that focuses on investing in early-stage companies developing disruptive innovations with a positive societal impact. Managed by Sopartec, UCLouvain's technology transfer company, VIVES has been active for over 15 years, supporting spin-offs from UCLouvain and startups in Belgium and neighboring countries. The fund's investment strategy encompasses various technological sectors, including biotechnology, medtech, agtech, engineering, and aerospace. VIVES invests at different stages of company development, from seed to growth phases, with individual investments ranging from €100,000 to €7 million. The fund primarily operates in Belgium, France, the Netherlands, and Luxembourg, aiming to accelerate the transformation of research into societal benefits. VIVES has a strong track record, with its portfolio companies collectively raising approximately €1.25 billion. Notable investments include iTeos Therapeutics, Novadip, Tessares, Axinesis, Botalys, Upstreem, Virovet, E-Peas, Aphea, and Syndesi. The fund's mission is to bridge the gap between academic research and market applications, fostering innovation and contributing to economic development in the region.
Investment Focus
- Early-stage technology companies with disruptive innovations
- Positive societal impact
- Located in Belgium or neighboring countries
Portfolio Companies
Reach VIVES Louvain Technology Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about VIVES Louvain Technology Fund
What sectors does VIVES Louvain Technology Fund invest in?
VIVES Louvain Technology Fund invests in Technology, Aerospace, Medtech, Agtech, Biotechnology and Engineering, and is based in Ottignies-Louvain-La-Neuve, Walloon Region, Belgium. VIVES Louvain Technology Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does VIVES Louvain Technology Fund invest at?
VIVES Louvain Technology Fund backs companies at Seed, Early Stage and Growth, writing cheques of 100K - 7M.
Which regions does VIVES Louvain Technology Fund invest in?
VIVES Louvain Technology Fund invests across France, Luxembourg, Netherlands and Belgium.
What companies has VIVES Louvain Technology Fund invested in?
VIVES Louvain Technology Fund's portfolio includes iTeos Therapeutics, E-peas, ViroVet, Botalys, Novadip, Tessares, Axinesis and Upstreem.
How do I contact VIVES Louvain Technology Fund?
VIVES Louvain Technology Fund's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
